Holen Sie sich die Stockscreener-App
103.86
0.65%
0.67
Schlusskurs vom Vortag:
$103.19
Offen:
$104.21
24-Stunden-Volumen:
1.09M
Relative Volume:
1.17
Marktkapitalisierung:
$6.76B
Einnahmen:
$1.54B
Nettoeinkommen (Verlust:
$233.56M
KGV:
30.85
EPS:
3.3669
Netto-Cashflow:
$348.64M
1W Leistung:
-0.44%
1M Leistung:
+11.52%
6M Leistung:
+60.18%
1J Leistung:
+31.48%
1-Tages-Spanne:
$102.97
$105.00
1-Wochen-Bereich:
$101.61
$107.99
52-Wochen-Spanne:
$47.25
$107.99
Lantheus Holdings Inc Stock (LNTH) Company Profile
Firmenname
Lantheus Holdings Inc
Sektor
Telefon
978 671-8001
Adresse
331 TREBLE COVE ROAD, NORTH BILLERICA, MA
Compare LNTH vs TAK, HLN, TEVA, ZTS, UTHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LNTH
Lantheus Holdings Inc
|
103.86 | 6.76B | 1.54B | 233.56M | 348.64M | 3.3669 |
TAK
Takeda Pharmaceutical Co Adr
|
15.63 | 49.39B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
8.96 | 39.55B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
31.48 | 36.66B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
78.71 | 33.00B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
536.59 | 22.78B | 3.17B | 1.29B | 1.01B | 27.09 |
Lantheus Holdings Inc Stock (LNTH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-26 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2025-12-12 | Hochstufung | Truist | Hold → Buy |
| 2025-10-08 | Herabstufung | Goldman | Buy → Neutral |
| 2025-08-12 | Herabstufung | Truist | Buy → Hold |
| 2024-12-18 | Eingeleitet | Goldman | Buy |
| 2024-09-03 | Eingeleitet | Redburn Atlantic | Buy |
| 2024-07-10 | Bestätigt | JMP Securities | Mkt Outperform |
| 2023-12-18 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2023-12-04 | Eingeleitet | TD Cowen | Outperform |
| 2023-09-29 | Eingeleitet | William Blair | Outperform |
| 2023-03-08 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2022-11-30 | Eingeleitet | SVB Leerink | Outperform |
| 2022-10-13 | Eingeleitet | Mizuho | Buy |
| 2022-05-09 | Eingeleitet | B. Riley Securities | Buy |
| 2022-04-13 | Eingeleitet | Truist | Buy |
| 2021-02-01 | Eingeleitet | SVB Leerink | Outperform |
| 2020-06-29 | Fortgesetzt | Jefferies | Buy |
| 2019-08-16 | Hochstufung | CJS Securities | Market Perform → Market Outperform |
| 2017-11-02 | Hochstufung | Wells Fargo | Market Perform → Outperform |
| 2016-11-08 | Bestätigt | RBC Capital Mkts | Outperform |
| 2016-09-23 | Fortgesetzt | Credit Suisse | Neutral |
| 2016-02-24 | Bestätigt | RBC Capital Mkts | Outperform |
| 2015-12-11 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2015-09-30 | Herabstufung | Wells Fargo | Outperform → Market Perform |
| 2015-07-20 | Eingeleitet | Credit Suisse | Outperform |
| 2015-07-20 | Eingeleitet | Jefferies | Buy |
| 2015-07-20 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2015-07-20 | Eingeleitet | Robert W. Baird | Outperform |
| 2015-07-20 | Eingeleitet | Wells Fargo | Outperform |
Alle ansehen
Lantheus Holdings Inc Aktie (LNTH) Neueste Nachrichten
Lantheus Holdings Inc (LNTH) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Lantheus (LNTH) Proxy filing Summary - Quartr
Lantheus Holdings Inc (LNTH) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Lantheus Holdings Inc (LNTH) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Lantheus Holdings Inc (LNTH) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Lantheus Holdings Inc (LNTH) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Lantheus Holdings Inc (LNTH) Valuation: PE, PB & Fair Value Analysis - TradingKey
Lantheus Holdings Inc (LNTH) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Lantheus Holdings Inc (LNTH) Institutional Confidence - TradingKey
Why Is LNTH Stock Up After Hours? - Stocktwits
Why (LNTH) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Lantheus Holdings Inc (LNTH) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Lantheus Holdings (LNTH) Holds Steady as Shares Trade Near Midpoint of Key RangeOption Strike Build - newsline.com
LNTH Q1 2026 Earnings: EPS Surprises to the Upside on Solid Operational ExecutionSurprise Factor Analysis - newsline.com
Healthcare Stocks to Avoid: Lantheus, Merit Medical, Addus HomeCare AnalysisNews and Statistics - IndexBox
Lantheus Holdings stock hits 52-week high at 104.05 USD By Investing.com - Investing.com Nigeria
How SNMMI’s ‘Image of the Year’ Win For LNTH-2513 At Lantheus (LNTH) Has Changed Its Investment Story - Sahm
Lantheus Holdings stock hits 52-week high at 104.05 USD - Investing.com
Metastatic Prostate Cancer Market Set for Robust Growth Through 2036, Driven by The Emergence of PARP Inhibitors and PSMA-targeted Radioligand Therapies | DelveInsight - GlobeNewswire Inc.
Lantheus Holdings Inc stock (US5156731020): Expansion push and TruVu launch keep radiopharma story i - AD HOC NEWS
Lantheus Holdings gains after report it's evaluating a sale after offer - MSN
LNTH: TruVu launches regionally in late 2024, expanding PYLARIFY access and driving market growth - TradingView
Lantheus Holdings Inc at Goldman Sachs Healthcare Conference Transcript - GuruFocus
Lantheus Holdings, Inc. (LNTH): Analyst Consensus Highlights a Strong Buy with a 4.21% Upside Potential - DirectorsTalk Interviews
Cash from financing activities of Lantheus Holdings Inc – XETR:0L8 - TradingView
0L8 Stock Price and Chart — XETR:0L8 - TradingView
Lantheus Holdings Inc Statistics – XETR:0L8 - TradingView
ETFs Investing in Lantheus Holdings Inc Stocks - TradingView
Assessing Lantheus Holdings (LNTH) Valuation After Strong Multi Month Share Price Gains - Yahoo Finance
Understanding Momentum Shifts in (LNTH) - Stock Traders Daily
Lantheus in the spotlight: Can pipeline offset pricing headwinds? By Investing.com - Investing.com Nigeria
William Blair Upgrades Lantheus(LNTH.US) to Buy Rating - Moomoo
Is Lantheus Holdings Inc (LNTH) Overvalued After 4.1% Rally? GF - GuruFocus
Lantheus (LNTH) director uses 381 shares for tax-withholding, retains over 27,000 - Stock Titan
Lantheus (LNTH) CEO Heino reports 1,227-share tax withholding and updated holdings - Stock Titan
Lantheus Holdings Jumps 5.0% Amid Sector-Wide Rally - AlphaStreet
Lantheus (LNTH) 46th Annual William Blair Growth Stock Conference Summary - Quartr
LNTH: Isotope-driven innovation and robust supply chains fuel PET imaging growth and new product launches - TradingView
Lantheus to Present at the Goldman Sachs 47th Annual Global Healthcare Conference - The Manila Times
FDA approves Lantheus’ PYLARIFY TruVu for prostate cancer imaging - Investing.com
Lantheus' LNTH-2513 (18F-GP1) PET/CT Awarded SNMMI’s Image of the Year - The Manila Times
PET scan for deep vein thrombosis wins SNMMI Image of the Year - Stock Titan
Lantheus Holdings, Inc. (LNTH) Investor Outlook: High Buy Ratings and Promising Growth Prospects - DirectorsTalk Interviews
Lantheus Holdings (LNTH) price target increased by 10.39% to 103.33 - MSN
Lantheus Q1 2026 Earnings: EPS Beat of 15.85% Amid Flat Revenue DisclosureEPS Revision Trend - newsline.com
LNTH Stock Price, Quote & Chart | LANTHEUS HOLDINGS INC (NASDAQ:LNTH) - ChartMill
LNTH Maintains by Mizuho -- Price Target Raised to $115 - GuruFocus
Mizuho raises Lantheus stock price target to $115 amid sale talks - Investing.com UK
Mizuho Securities Maintains Lantheus(LNTH.US) With Buy Rating, Raises Target Price to $115 - Moomoo
Analysts Are Bullish on Top Healthcare Stocks: IQVIA Holdings (IQV), Lantheus (LNTH) - The Globe and Mail
Lantheus to present at William Blair Growth Stock Conference on June 3, highlighting its radiopharmaceutical advances. - Pluang
Finanzdaten der Lantheus Holdings Inc-Aktie (LNTH)
Umsatz
Nettogewinn
Free Cashflow
ENV
11.23%
0.45%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):